| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 86.00M | 86.00M | 62.21M | 79.88M | 70.66M | 60.51M |
| Gross Profit | 26.17M | 26.17M | 16.86M | 23.74M | 21.66M | 18.24M |
| EBITDA | 11.78M | 12.24M | 3.98M | 10.01M | 11.66M | 10.23M |
| Net Income | 7.01M | 7.01M | 1.51M | 6.21M | 7.13M | 6.00M |
Balance Sheet | ||||||
| Total Assets | 86.80M | 86.80M | 84.39M | 86.20M | 90.77M | 78.73M |
| Cash, Cash Equivalents and Short-Term Investments | 8.68M | 8.68M | 12.26M | 9.44M | 10.11M | 9.09M |
| Total Debt | 2.42M | 2.42M | 10.39M | 11.71M | 12.08M | 14.19M |
| Total Liabilities | 14.57M | 14.57M | 17.32M | 19.05M | 27.73M | 20.32M |
| Stockholders Equity | 72.23M | 72.23M | 67.07M | 67.15M | 63.04M | 58.42M |
Cash Flow | ||||||
| Free Cash Flow | 6.95M | 6.95M | 6.13M | 5.10M | 4.51M | 6.40M |
| Operating Cash Flow | 8.29M | 8.29M | 8.45M | 6.74M | 5.93M | 8.23M |
| Investing Cash Flow | -1.34M | -1.34M | -2.97M | -2.53M | -1.43M | -1.83M |
| Financing Cash Flow | -10.52M | -10.52M | -2.66M | -4.88M | -3.49M | -6.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | AU$116.06M | 16.55 | 10.07% | 2.06% | 38.25% | 361.54% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | AU$134.12M | 24.19 | 13.97% | ― | 28.66% | ― | |
45 Neutral | AU$23.34M | -5.75 | -29.43% | ― | 102.21% | 69.47% | |
43 Neutral | AU$27.14M | 35.22 | ― | ― | 6.76% | ― | |
38 Underperform | €27.50M | ― | -20.54% | ― | 13.92% | 36.28% | |
31 Underperform | AU$4.07M | -0.58 | ― | ― | -21.84% | 79.99% |
Clover Corporation Limited announced a change in the director’s interest, with Fiona Pearse acquiring 62,996 ordinary shares through an on-market purchase, increasing her total holdings to 149,028 shares. This transaction, valued at $40,050, reflects a strategic move by the director, potentially indicating confidence in the company’s future performance and stability, which could positively impact stakeholder perceptions.
The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
Clover Corporation Limited announced a change in the director’s interest, with Fiona Pearse acquiring an additional 31,000 ordinary shares through an on-market purchase, increasing her total holdings to 86,032 shares. This acquisition reflects a strategic move by the director, potentially signaling confidence in the company’s future performance and stability, which could have positive implications for stakeholders and market perception.
The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
Clover Corporation Limited has announced the details of its 2025 Annual General Meeting (AGM), scheduled for November 18, 2025, to be held in a hybrid format allowing both in-person and online participation. The AGM will provide shareholders an opportunity to engage with the company’s board, discuss the company’s performance, and vote on key resolutions. The company has also released its 2025 Annual Report, which is available on its website. The board recommends shareholders vote in favor of resolutions 2 to 6, while abstaining from a recommendation on resolution 1 due to its nature concerning the remuneration report.
The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.75 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
Clover Corporation Limited announced a change in the director’s interest, with Fiona Pearse acquiring an additional 14,492 ordinary shares through an on-market purchase, increasing her total holdings to 55,032 shares. This acquisition reflects a continued commitment to the company and may indicate confidence in its future performance, potentially impacting stakeholders’ perceptions and the company’s market positioning.
The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.75 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
Clover Corporation Limited has announced its intention to hold its annual general meeting (AGM) on 18 November 2025. The company has set the closing date for director nominations for 6 October 2025, in accordance with its constitution and ASX listing rules. This meeting is significant for stakeholders as it provides an opportunity for the election of directors, which could influence the company’s strategic direction and governance.
The most recent analyst rating on (AU:CLV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
Clover Corporation Limited has announced its annual report for the year ended 31 July 2025. The company has undergone changes in its board of directors with the appointment of Ms Fiona Pearse as a Non-Executive Director starting from 1 August 2025. This change in leadership could potentially impact the company’s strategic direction and operations.
The most recent analyst rating on (AU:CLV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
Clover Corporation Limited reported a strong financial performance for the fiscal year 2025, with a 38% increase in net sales revenue to $86 million and a significant rise in net profit after tax to $7 million. The company’s growth was driven by new product launches and improved operational performance, particularly at its Melody Dairies and Ecuador facilities. Clover’s strategic initiatives, including expanding its distribution model and investing in product development, have positioned it well for future growth. The company declared a final dividend of 1 cent per share, reflecting its robust financial health and cash generation capabilities.
The most recent analyst rating on (AU:CLV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
Clover Corporation Limited reported a significant financial improvement for the year ended July 31, 2025, with a 38% increase in total revenue to $86 million and a net profit after tax of $7 million, marking a 601% rise from the previous year. This financial growth reflects the company’s strengthened market position and operational success, benefiting stakeholders through increased dividends and a robust financial outlook.
The most recent analyst rating on (AU:CLV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
Clover Corporation Limited is set to release its FY25 financial results on September 23, 2025, before the market opens. The company will host a webinar on the same day, featuring presentations by the Managing Director and CEO, Peter Davey, and CFO, Andrew Allibon, who will discuss the year’s business activities and highlights. This announcement is part of Clover’s ongoing efforts to engage with investors and stakeholders, reflecting its commitment to transparency and strategic growth in the nutritional ingredients sector.
The most recent analyst rating on (AU:CLV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.